Radiopharmaceutical Therapy Part II: Clinical Aspects


This follow-up to the safety discussion of radiopharmaceuticals explores the clinical aspects of new therapeutic radiopharmaceuticals. Experts will walk you through some of the clinical challenges and discuss currently approved drugs along with a selection of drugs now in successful clinical trials.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to: 

  1. Describe the current place in therapy for new pharmaceuticals radiolabeled with iodine-131, radium-223, and lutetium-177. 
  2. List alpha-emitting radioisotopes that are currently in phase II or phase III clinical trials.
Aaron Jessop,
Associate Professor of Clinical Radiology
Vanderbilt University Medical Center
Learning Level: Level 2
Track: Nuclear Pharmacy
Session Time Slot(s): 
Sunday, March 18
3:30 PM - 5:30 PM
Music City Center - Room 105A
ACPE Pharmacist: 0202-0000-18-080-L01-P
CEUs Pharmacist: 0.2
Activity Type: